BN Business News
Add your company to Business Communicator →

Business · 03/08/2017Updated: 10/17/2026 · 1 min read

B. Braun Medical, Inc. Withdraws FDA Approval of Three New Drug Applications and One Abbreviated New Drug Application

Summary

B. Braun Medical, Inc. has requested the FDA to withdraw approval of three new drug applications and one abbreviated new drug application, citing that the corresponding drug products are no longer being marketed.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →